Clinical Trial

SakuraBead Used as Resorbable Embolic for Plantar Fascia Embolization

Study acronym: SURE-PF
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 21, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, single center, double arm, randomized, unmasked, First in Human study that aims to evaluate the safety and effectiveness of SakuraBead™ resorbable embolization microspheres in adult patients suffering from pain secondary to plantar fasciitis.
Trial Details
NCT Number NCT07241884
Lead Sponsor CrannMed
Conditions Plantar Fascitis, Heel Pain, Musculoskeletal Diseases
Enrollment 45 participants
Start Date 2025-10-20
Primary Completion 2026-06 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2025-11-21